These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28640832)

  • 1. Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice.
    Lee ES; Lee MY; Kwon MH; Kim HM; Kang JS; Kim YM; Lee EY; Chung CH
    PLoS One; 2017; 12(6):e0179221. PubMed ID: 28640832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.
    Kobayashi S; Satoh M; Namikoshi T; Haruna Y; Fujimoto S; Arakawa S; Komai N; Tomita N; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2008 Apr; 12(2):119-125. PubMed ID: 18175064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.
    Chow F; Ozols E; Nikolic-Paterson DJ; Atkins RC; Tesch GH
    Kidney Int; 2004 Jan; 65(1):116-28. PubMed ID: 14675042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db/db mice.
    Terami N; Ogawa D; Tachibana H; Hatanaka T; Wada J; Nakatsuka A; Eguchi J; Horiguchi CS; Nishii N; Yamada H; Takei K; Makino H
    PLoS One; 2014; 9(6):e100777. PubMed ID: 24960177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lymphatic proliferation by the selective VEGFR-3 inhibitor SAR131675 ameliorates diabetic nephropathy in db/db mice.
    Hwang SD; Song JH; Kim Y; Lim JH; Kim MY; Kim EN; Hong YA; Chung S; Choi BS; Kim YS; Park CW
    Cell Death Dis; 2019 Mar; 10(3):219. PubMed ID: 30833548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel chalcone derivative attenuates the diabetes-induced renal injury via inhibition of high glucose-mediated inflammatory response and macrophage infiltration.
    Fang Q; Zhao L; Wang Y; Zhang Y; Li Z; Pan Y; Kanchana K; Wang J; Tong C; Li D; Liang G
    Toxicol Appl Pharmacol; 2015 Jan; 282(2):129-38. PubMed ID: 25447405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.
    Cha DR; Zhang X; Zhang Y; Wu J; Su D; Han JY; Fang X; Yu B; Breyer MD; Guan Y
    Diabetes; 2007 Aug; 56(8):2036-45. PubMed ID: 17536062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate Mofetil Ameliorates Diabetic Nephropathy in db/db Mice.
    Seo JW; Kim YG; Lee SH; Lee A; Kim DJ; Jeong KH; Lee KH; Hwang SJ; Woo JS; Lim SJ; Kim W; Moon JY
    Biomed Res Int; 2015; 2015():301627. PubMed ID: 26345532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats.
    Pan Y; Wang Y; Cai L; Cai Y; Hu J; Yu C; Li J; Feng Z; Yang S; Li X; Liang G
    Br J Pharmacol; 2012 Jun; 166(3):1169-82. PubMed ID: 22242942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of TGF-β-activated kinase 1 in db/db mice and high glucose-induced macrophage.
    Xu X; Fan Z; Qi X; Shao Y; Wu Y
    Int Immunopharmacol; 2016 Sep; 38():120-31. PubMed ID: 27268284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An aqueous extract of Portulaca oleracea ameliorates diabetic nephropathy through suppression of renal fibrosis and inflammation in diabetic db/db mice.
    Lee AS; Lee YJ; Lee SM; Yoon JJ; Kim JS; Kang DG; Lee HS
    Am J Chin Med; 2012; 40(3):495-510. PubMed ID: 22745066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
    Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
    Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperoside Suppresses Renal Inflammation by Regulating Macrophage Polarization in Mice With Type 2 Diabetes Mellitus.
    Liu J; Zhang Y; Sheng H; Liang C; Liu H; Moran Guerrero JA; Lu Z; Mao W; Dai Z; Liu X; Zhang L
    Front Immunol; 2021; 12():733808. PubMed ID: 34925317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy.
    Jheng HF; Tsai PJ; Chuang YL; Shen YT; Tai TA; Chen WC; Chou CK; Ho LC; Tang MJ; Lai KT; Sung JM; Tsai YS
    Dis Model Mech; 2015 Oct; 8(10):1311-21. PubMed ID: 26398934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy.
    Choi SR; Lim JH; Kim MY; Kim EN; Kim Y; Choi BS; Kim YS; Kim HW; Lim KM; Kim MJ; Park CW
    Metabolism; 2018 Aug; 85():348-360. PubMed ID: 29462574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes.
    Lin Y; Sun Z
    J Endocrinol; 2011 May; 209(2):185-91. PubMed ID: 21307121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: role of the heme oxygenase/atrial natriuretic peptide/adiponectin axis.
    Ndisang JF; Jadhav A
    Endocrinology; 2014 Jan; 155(1):215-29. PubMed ID: 24140713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitophagy regulates macrophage phenotype in diabetic nephropathy rats.
    Zhao Y; Guo Y; Jiang Y; Zhu X; Liu Y; Zhang X
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):42-50. PubMed ID: 29061302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a CCR2 antagonist on macrophages and Toll-like receptor 9 expression in a mouse model of diabetic nephropathy.
    Ito S; Nakashima H; Ishikiriyama T; Nakashima M; Yamagata A; Imakiire T; Kinoshita M; Seki S; Kumagai H; Oshima N
    Am J Physiol Renal Physiol; 2021 Dec; 321(6):F757-F770. PubMed ID: 34719947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes.
    Li Z; Li Y; Overstreet JM; Chung S; Niu A; Fan X; Wang S; Wang Y; Zhang MZ; Harris RC
    Diabetes; 2018 Sep; 67(9):1847-1857. PubMed ID: 29959129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.